These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 2704969)
1. [Methods of evaluating chondroprotective treatment]. Dougados M; Duchesne L Rev Prat; 1989 Mar; 39(7):575-7. PubMed ID: 2704969 [TBL] [Abstract][Full Text] [Related]
2. A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models. Baragi VM; Becher G; Bendele AM; Biesinger R; Bluhm H; Boer J; Deng H; Dodd R; Essers M; Feuerstein T; Gallagher BM; Gege C; Hochgürtel M; Hofmann M; Jaworski A; Jin L; Kiely A; Korniski B; Kroth H; Nix D; Nolte B; Piecha D; Powers TS; Richter F; Schneider M; Steeneck C; Sucholeiki I; Taveras A; Timmermann A; Van Veldhuizen J; Weik J; Wu X; Xia B Arthritis Rheum; 2009 Jul; 60(7):2008-18. PubMed ID: 19565489 [TBL] [Abstract][Full Text] [Related]
3. [Do 'chondroprotective agents' agents exist in osteoarthritis? Required proof]. Lequesne M; Cadet C Therapie; 1998; 53(1):7-16. PubMed ID: 9773094 [TBL] [Abstract][Full Text] [Related]
4. Cartilage degradation: is there a place for chondroprotective agents? A symposium of the American College of Rheumatology. Cincinnati, Ohio, June 17, 1989. Proceedings. Semin Arthritis Rheum; 1990 Feb; 19(4 Suppl 1):1-32. PubMed ID: 2315704 [No Abstract] [Full Text] [Related]
5. Prevention of cartilage degeneration in a rat model of osteoarthritis by intraarticular treatment with recombinant lubricin. Flannery CR; Zollner R; Corcoran C; Jones AR; Root A; Rivera-Bermúdez MA; Blanchet T; Gleghorn JP; Bonassar LJ; Bendele AM; Morris EA; Glasson SS Arthritis Rheum; 2009 Mar; 60(3):840-7. PubMed ID: 19248108 [TBL] [Abstract][Full Text] [Related]
6. Differential anti-inflammatory and chondroprotective effects of simulated digests of indomethacin and an herbal composite (Mobility) in a cartilage explant model of articular inflammation. Pearson W; Orth MW; Lindinger MI J Vet Pharmacol Ther; 2007 Dec; 30(6):523-33. PubMed ID: 17991220 [TBL] [Abstract][Full Text] [Related]
7. [Drug treatment of rheumatoid arthritis and osteoarthritis]. Trnavský K; Pavelka K Z Gesamte Inn Med; 1987 Aug; 42(15):434-6. PubMed ID: 2890243 [TBL] [Abstract][Full Text] [Related]
9. Phosphate prodrugs derived from N-acetylglucosamine have enhanced chondroprotective activity in explant cultures and represent a new lead in antiosteoarthritis drug discovery. McGuigan C; Serpi M; Bibbo R; Roberts H; Hughes C; Caterson B; Gibert AT; Verson CR J Med Chem; 2008 Sep; 51(18):5807-12. PubMed ID: 18714981 [TBL] [Abstract][Full Text] [Related]
10. An update review of cellular mechanisms conferring the indirect and direct effects of estrogen on articular cartilage. Tankó LB; Søndergaard BC; Oestergaard S; Karsdal MA; Christiansen C Climacteric; 2008 Feb; 11(1):4-16. PubMed ID: 18202960 [TBL] [Abstract][Full Text] [Related]
11. Guidelines for testing slow acting drugs in osteoarthritis. Lequesne M; Brandt K; Bellamy N; Moskowitz R; Menkes CJ; Pelletier JP; Altman R J Rheumatol Suppl; 1994 Sep; 41():65-71; discussion 72-3. PubMed ID: 7799389 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and mechanism of action of KHBJ-9B, a new herbal medicine, and its major compound triterpenoids in human cartilage culture and in a rabbit model of collagenase-induced osteoarthritis. Huh JE; Baek YH; Ryu SR; Lee JD; Choi DY; Park DS Int Immunopharmacol; 2009 Feb; 9(2):230-40. PubMed ID: 19100343 [TBL] [Abstract][Full Text] [Related]
14. [The relation between the level of antibodies to the glycosaminoglycans of the cartilage in patients with osteoarthritis and the efficacy of treatment with chondroprotectors]. Zavodovskiĭ BV; Kovalenko EA; Fofanova NA; Novikova OV; Zborovskiĭ AB Ter Arkh; 1999; 71(5):47-50. PubMed ID: 10399231 [TBL] [Abstract][Full Text] [Related]